Arthur, a venture-backed CB Insights AI Top 100 company, is seeking the first group of Account Executives to help us continue to bring our AI monitoring platform to market. This position marks a rare opportunity to bring responsible AI toolkits into the hands of leading executives in all industries with a focus on the finance, healthcare, and technology space. The AI monitoring industry is an emerging market with significant financial opportunity, little competition, and no cap on commission. Arthur is a young and exciting NYC startup that has been featured in WIRED and TechCrunch, having emerged from stealth late last year.

As an AE at Arthur you will…

• Own the sales cycle for your target accounts from initial contact to close

• Expand accounts from POC to annual contracts

• Engage with C-suite and VP level data science leaders, consultatively

• Help install sales measurement/documentation best practices

• Work with a close, tightly-knit group of industry thought leaders and advocates

Requirements:

• 2-4 years SaaS sales experience

• Experience prospecting and initiating cold contact

• Excellent verbal/presentation skills

• Track record of meeting/exceeding goals

• Stellar negotiating and closing ability

Preferred Qualifications:

• 4-6 years SaaS sales experience

• AI industry experience or familiarity with the space

• Bachelors, Masters, and/or PhD degree (preferred, NOT required)

• Experience closing in the financial or healthcare industries

We offer:

• Generous base salary commensurate with experience and uncapped commission in an emerging market with limitless prospects and significant unfilled need

• Working with a small, fast-growing team, lots of opportunity to take ownership and run with projects

• The opportunity to get in on the ground floor of a rapidly growing startup, working in an emerging space with market-making professionals

• Generous equity

• A culture that empowers great people to accomplish great things

• Full benefits package

• We are fully remote for the foreseeable future given concerns about the novel virus